by According to Precedence Research, during the forecast period of 2022 to 2030, the global injectable drugs delivery market is estimated to develop at a compound annual growth rate (CAGR) of 9.05%. The global injectable drugs delivery market was valued at USD 9.05 billion in 2021, and it is predicted to exceed USD 1,223.6 billion by 2030. The study investigates several elements and their consequences on the growth of the injectable drugs delivery market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1760
This report focuses on injectable drugs delivery market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall injectable drugs delivery market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of injectable drugs delivery, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of injectable drugs delivery has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the injectable drugs delivery market.
Some of the prominent players in the injectable drugs delivery market include:
- Becton
- Dickinson and Company
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Eli Lilly and Company
- Baxter International, Inc.
- Sandoz
- Terumo
- Schott AG
- Gerresheimer
- Ypsomed
- Bespak
- B. Braun Melsungen
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1760
Segments Covered in the Report
By Type
- Devices
- Formulations
By Formulation Packaging
- Ampules
- Vials
- Cartridges
- Bottles
By Therapeutic Application
- Auto-immune diseases
- Hormonal Disorders
- Orphan Diseases
- Oncology
- Other Therapeutic Applications
By Usage Pattern
- Curative Care
- Immunization
- Other Usage Pattern
By Site of Administration
- Skin
- Circulatory/Musculoskeletal
- Organs
- Central Nervous System
By Distribution Channel
- Hospitals
- Retail Pharmacy Stores
By Facility of Use
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Injectable Drugs Delivery Market, By Type
7.1. Injectable Drugs Delivery Market, by Type, 2022-2030
7.1.1. Devices
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Formulations
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Injectable Drugs Delivery Market, By Formulation Packaging
8.1. Injectable Drugs Delivery Market, by Formulation Packaging, 2022-2030
8.1.1. Ampules
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Vials
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Cartridges
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.3. Bottles
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Injectable Drugs Delivery Market, By Therapeutic Application
9.1. Injectable Drugs Delivery Market, by Therapeutic Application, 2022-2030
9.1.1. Auto-immune diseases
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Hormonal Disorders
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Orphan Diseases
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Oncology
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Other Therapeutic Applications
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Injectable Drugs Delivery Market, By Usage Pattern
10.1. Injectable Drugs Delivery Market, by Usage Pattern, 2022-2030
10.1.1. Curative Care
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Immunization
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Other Usage Pattern
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Injectable Drugs Delivery Market, By Site of Administration
11.1. Injectable Drugs Delivery Market, by Site of Administration, 2022-2030
11.1.1. Skin
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Circulatory/Musculoskeletal
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Organs
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Central Nervous System
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Injectable Drugs Delivery Market, By Distribution Channel
12.1. Injectable Drugs Delivery Market, by Distribution Channel, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Retail Pharmacy Stores
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Injectable Drugs Delivery Market, By Facility of Use
13.1. Injectable Drugs Delivery Market, by Facility of Use, 2022-2030
13.1.1. Hospitals & Clinics
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Home Care Settings
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.2. Other Facilities of Use
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Injectable Drugs Delivery Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.1.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.1.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.1.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.1.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.1.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.1.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.1.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.1.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.10.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.10.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.11.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.11.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.10.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.10.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.11.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.11.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.10.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.10.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.11.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.11.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.5.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.5.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.5.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.5.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.5.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.5.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.5.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 15. Company Profiles
15.1. Becton
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Dickinson and Company
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Pfizer Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Teva Pharmaceuticals Industries Ltd.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Eli Lilly and Company
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Baxter International, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Sandoz
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Terumo
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Schott AG
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Gerresheimer
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1760
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
